- Home
- IRON vs PRDO Comparison
IRON vs PRDO Comparison
Compare IRON & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- PRDO
- Stock Information
- Founded
- IRON 2017
- PRDO 1994
- Country
- IRON United States
- PRDO United States
- Employees
- IRON N/A
- PRDO N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- PRDO Other Consumer Services
- Sector
- IRON Health Care
- PRDO Real Estate
- Exchange
- IRON Nasdaq
- PRDO Nasdaq
- Market Cap
- IRON 2.1B
- PRDO 2.3B
- IPO Year
- IRON N/A
- PRDO N/A
- Fundamental
- Price
- IRON $85.63
- PRDO $36.82
- Analyst Decision
- IRON Strong Buy
- PRDO Buy
- Analyst Count
- IRON 13
- PRDO 1
- Target Price
- IRON $102.23
- PRDO $42.00
- AVG Volume (30 Days)
- IRON 623.6K
- PRDO 397.6K
- Earning Date
- IRON 11-11-2025
- PRDO 11-04-2025
- Dividend Yield
- IRON N/A
- PRDO 1.63%
- EPS Growth
- IRON N/A
- PRDO 12.96
- EPS
- IRON N/A
- PRDO 2.30
- Revenue
- IRON N/A
- PRDO $768,844,000.00
- Revenue This Year
- IRON N/A
- PRDO $25.27
- Revenue Next Year
- IRON N/A
- PRDO $4.01
- P/E Ratio
- IRON N/A
- PRDO $16.04
- Revenue Growth
- IRON N/A
- PRDO 15.99
- 52 Week Low
- IRON $30.82
- PRDO $20.97
- 52 Week High
- IRON $95.95
- PRDO $38.03
- Technical
- Relative Strength Index (RSI)
- IRON 69.02
- PRDO 61.94
- Support Level
- IRON $83.52
- PRDO $34.55
- Resistance Level
- IRON $89.00
- PRDO $35.76
- Average True Range (ATR)
- IRON 3.84
- PRDO 0.84
- MACD
- IRON 1.08
- PRDO 0.07
- Stochastic Oscillator
- IRON 64.05
- PRDO 85.33
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.